fingolimod hydrochloride has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Huang, C; Huang, QK; Li, EC; Li, FJ; Ling, R; Liu, BG; You, SW | 1 |
| Egen, JG; Germain, RN; Ishii, M; Klauschen, F; Meier-Schellersheim, M; Proia, RL; Saeki, Y; Vacher, J | 1 |
2 other study(ies) available for fingolimod hydrochloride and Osteoporosis
| Article | Year |
|---|---|
FTY720 enhances osteogenic differentiation of bone marrow mesenchymal stem cells in ovariectomized rats.
Topics: Animals; Antigens, CD; Biomarkers; Bone and Bones; Cell Differentiation; Cell Self Renewal; Female; Fingolimod Hydrochloride; Gene Expression Profiling; Gene Expression Regulation; Immunophenotyping; Mesenchymal Stem Cells; Osteogenesis; Osteoporosis; Ovariectomy; Rats | 2016 |
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis.
Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Cell Line; Cell Lineage; Chemotaxis; Female; Fingolimod Hydrochloride; Homeostasis; Lysophospholipids; Mice; Mice, Inbred C57BL; Monocytes; Osteoclasts; Osteoporosis; Ovariectomy; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine | 2009 |